search
Back to results

Quality of Life With Bone Conduction Hearing Device

Primary Purpose

Conductive Hearing Loss

Status
Recruiting
Phase
Not Applicable
Locations
Austria
Study Type
Interventional
Intervention
Bone conduction device (ADHEAR)
Sponsored by
Medical University of Vienna
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Conductive Hearing Loss

Eligibility Criteria

13 Years - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Unilateral and/or bilateral conductive hearing loss (CHL)
  • Conductive hearing loss >10 decibel on average
  • Subjective benefit from the device
  • Subjects aged 13 years or older
  • Capable of the German language
  • Willingness and ability to perform all tests required for the study
  • Signed, and dated informed consent before the start of any study specific procedure

Exclusion Criteria:

  • Pregnancy or breastfeeding
  • Patient uses a hearing aid or plans to acquire a hearing aid
  • Patient is intolerant of the materials as described by Manufacturer
  • Patient presents with a skin or scalp condition that may preclude the attachment of the adhesive adapter.
  • Patient cannot perform the audiological tests or is unable to fill out the questionnaires.
  • Patient presents with retrocochlear, or central auditory disorder.
  • any physical, psychological, or emotional disorder that would interfere with the ability to perform on test and rehabilitation procedures

Sites / Locations

  • MUW AKHRecruiting

Arms of the Study

Arm 1

Arm Type

Other

Arm Label

Bone conduction device - ADHEAR

Arm Description

Patients will receive a hearing aid (ADHEAR). Hearing assessment will be carried out. Quality of life measurement will be carried out.

Outcomes

Primary Outcome Measures

AQoL (Assessment of Quality of Life) Results
The primary objective of this study is to evaluate, whether patients using ADHEAR have a significantly improved quality of life compared to patients not fitted with a device with the AQoL (Assessment of Quality of Life) questionnaire. It comprises 35 questions covering a multitude of quality of life aspects. Weighted utilities are generated using the algorithms provided on the AQoL website. Weighted utilities give a number between 0 and 1 as answer for every question. These sub scores are then presented.

Secondary Outcome Measures

Full Information

First Posted
February 24, 2019
Last Updated
October 20, 2023
Sponsor
Medical University of Vienna
search

1. Study Identification

Unique Protocol Identification Number
NCT03864731
Brief Title
Quality of Life With Bone Conduction Hearing Device
Official Title
Audiological Benefit and Improved Quality of Life in Patients With a Bone Conduction Device - a Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
October 2023
Overall Recruitment Status
Recruiting
Study Start Date
February 25, 2019 (Actual)
Primary Completion Date
December 31, 2024 (Anticipated)
Study Completion Date
December 31, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Medical University of Vienna

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
The aim of this study is to compare the audiological and quality of life performance patients have with an ADHEAR (adhesive bone conduction device) compared to no hearing device.
Detailed Description
Patients will be recruited at the outpatient's department of the Medical University of Vienna - Otorhinolaryngology department. Patient will be asked to participate in the study when inclusion and exclusion criteria are met. Mostly patients scheduled for a surgery improving conductive hearing loss or scheduled for implantation of an implantable bone conduction hearing aid will be included in the study. Patients who do not use a hearing aid and who are not planning on using a hearing aid meeting the inclusion and exclusion criteria will also be asked to participate in the study. After inclusion in the study patients will be asked to fill out two questionnaires (quality of life and hearing specific questionnaire). They will then be fitted with an ADHEAR device and undergo unaided and aided soundfield audiometry. Randomization will be carried out (Randomization ratio 1.4:1) and patients in the intervention group will keep the device for the following 4 months with one visit after the first probation time of one month. At the one month mark patients in the control group will be asked to fill out the two questionnaires. Patients in the control group will be asked to return to the department and fill out the three questionnaires (SSQ-12 (Speech Spatial and Hearing Questionnaire), AQoL(Assessment of Quality of Life) and In-house questionnaire). Further audiologic assessment will be carried out. At this appointment patients will be able to talk about their experiences in the probation period und easily terminate the study in case of insufficient improvement, pain, skin irritations or other issues. At the four month mark patients in both groups will be asked to return for audiologic assessment and for filling out the questionnaires.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Conductive Hearing Loss

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
36 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Bone conduction device - ADHEAR
Arm Type
Other
Arm Description
Patients will receive a hearing aid (ADHEAR). Hearing assessment will be carried out. Quality of life measurement will be carried out.
Intervention Type
Device
Intervention Name(s)
Bone conduction device (ADHEAR)
Intervention Description
adhesive bone conduction device
Primary Outcome Measure Information:
Title
AQoL (Assessment of Quality of Life) Results
Description
The primary objective of this study is to evaluate, whether patients using ADHEAR have a significantly improved quality of life compared to patients not fitted with a device with the AQoL (Assessment of Quality of Life) questionnaire. It comprises 35 questions covering a multitude of quality of life aspects. Weighted utilities are generated using the algorithms provided on the AQoL website. Weighted utilities give a number between 0 and 1 as answer for every question. These sub scores are then presented.
Time Frame
4 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
13 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Unilateral and/or bilateral conductive hearing loss (CHL) Conductive hearing loss >10 decibel on average Subjective benefit from the device Subjects aged 13 years or older Capable of the German language Willingness and ability to perform all tests required for the study Signed, and dated informed consent before the start of any study specific procedure Exclusion Criteria: Pregnancy or breastfeeding Patient uses a hearing aid or plans to acquire a hearing aid Patient is intolerant of the materials as described by Manufacturer Patient presents with a skin or scalp condition that may preclude the attachment of the adhesive adapter. Patient cannot perform the audiological tests or is unable to fill out the questionnaires. Patient presents with retrocochlear, or central auditory disorder. any physical, psychological, or emotional disorder that would interfere with the ability to perform on test and rehabilitation procedures
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Valerie Dahm, MD
Phone
+4314040033300
Email
valerie.dahm@meduniwien.ac.at
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Dominik Riss, MD
Organizational Affiliation
MUW
Official's Role
Principal Investigator
Facility Information:
Facility Name
MUW AKH
City
Vienna
ZIP/Postal Code
1090
Country
Austria
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Valerie Dahm, MD
Phone
004314040033300
Email
valerie.dahm@meduniwien.ac.at

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Quality of Life With Bone Conduction Hearing Device

We'll reach out to this number within 24 hrs